PharmaVoice

AUGUST 9, 2023

Children’s Tumor Foundation president Annette Bakker is working to teach the industry the crucial difference between drug repurposing and drug repositioning.

246

246

STAT

AUGUST 11, 2023

The last time Kim Kardashian posted about medical imaging, it was to prove her butt was real. Now, she’s praising its ability to find aneurysms and cancers before they turn deadly. Kardashian’s Instagram post this week about Prenuvo, which sells full-body MRI scans that can run in the thousands of dollars, has renewed a long-running debate about whether the tests are actually valuable or just run the risk of clogging hospitals with false positives and unnecessary follow-ups from we

Hospitals 246

Hospitals 246

ALiEM - Pharm Pearls

AUGUST 9, 2023

Read this tutorial on the use of point of care ultrasonography (POCUS) for pediatric lung ultrasound. Then test your skills on the ALiEMU course page to receive your PEM POCUS badge worth 2 hours of ALiEMU course credit. Take the ALiEMU PEM POCUS: Pediatric Lung Ultrasound Quiz Module Goals List indications for performing a pediatric lung point-of-care ultrasound (POCUS).

246

246

BioPharma Dive

AUGUST 10, 2023

The deal will help fund a cell-based treatment that completed Phase 1 testing last year and is designed to provide a “functional cure” for patients with HIV infections.

97

97

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

AUGUST 8, 2023

Ozempic and Wegovy have become household names for weight loss. But obesity is complex, and Phenomix Sciences is looking to bring a personalized medicine approach to the field.

242

242

STAT

AUGUST 11, 2023

HELSINKI — It was the quiet that stood out to Tarja Sironen at the fur farm. A specialist in emerging infectious diseases, Sironen has conducted research at fur farms for years. She helped develop a Covid vaccine that was deployed to the country’s mink population during the pandemic. She knows the industry well.

Vaccines 246

Vaccines 246

PharmExec

AUGUST 11, 2023

How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.

98

98

PharmaVoice

AUGUST 7, 2023

Although research on using oxytocin as a drug has varied, Tonix Pharmaceuticals is banking on the “love hormone” to treat autism, anxiety and more.

244

244

STAT

AUGUST 10, 2023

As a new class of obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for nearly half of the patients with insurance claims for GLP-1 prescriptions in 2022.

246

246

FADIC

AUGUST 11, 2023

Antibiotic Interactions: Avoid for Safe Medication Antibiotic Interactions: Combinations to Avoid for Safe Medication 🧵Some combinations of antibiotics and non-antibiotics that should be avoided💊🚫 1. Flucloxacillin β-lactams are considered to be less prone to drug interactions. Flucloxacillin, however, may ⬇️ tacrolimus concentration, presumably through enzyme induction The same can occur with flucloxacillin and broad-spectrum azoles (vori/posa) LINK 2

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmExec

AUGUST 11, 2023

From public defender to spearheading the adoption of innovative drugs, Wendy Short Bartie, senior VP and general manager for the hematology and cell therapy division at Bristol Myers Squibb, has remained a steadfast patient advocate—working to fulfill unmet medical needs and bring treatments to as many people as possible.

98

98

PharmaVoice

AUGUST 7, 2023

Immunotherapy has revolutionized cancer treatment, yet the drug discovery process to develop new biotherapeutic antibodies remains arduous.

246

246

STAT

AUGUST 10, 2023

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome. What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December , Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were

246

246

BioPharma Dive

AUGUST 10, 2023

The drug, which will be sold under the brand name Talvey, is now cleared by the FDA to treat multiple myeloma, a blood cancer that J&J has identified as a research priority.

98

98

The Pharmacist

AUGUST 11, 2023

While the flu vaccination service will officially begin in October, pharmacies will still be paid for vaccinating eligible patients who have already booked appointments for September, NHS England (NHSE) has announced. In a letter to flu vaccination providers, NHSE asked that the adult flu vaccination programme commence from October, confirming what it had earlier told […] The post Pharmacies to be paid for September flu jabs already booked appeared first on The Pharmacist.

Vaccines 94

Vaccines 94

Board Vitals - Pharmacist

AUGUST 10, 2023

The journey to becoming a certified surgical technologist is a noble one, filled with dedication, perseverance, and a commitment to excellence. At the heart of this journey lies a crucial milestone – the NBSTSA Surgical Technology Exam. This comprehensive exam contains 175 questions (150 graded) with a pass rate of just 73.7% in 2020. How can you best prepare for the CST exam ?

98

98

STAT

AUGUST 10, 2023

Carol Spence’s vision is flooded with green. As her brush swoops right and swishes left, she’s first transported to a lush spring meadow, then to the canopies of a rainforest — every stroke bringing her to another verdant utopia. Until she hears her daughter scream, “What are you doing?!

246

246

PharmExec

AUGUST 10, 2023

Hernandez details how the non-profit organization advocates for improved access to care at the community, state, and federal levels, and amplifies education and awareness efforts within its social media communities.

98

98

The Pharmacist

AUGUST 11, 2023

The risk of overdose from prescribed medicines used to overcome drug addiction is higher when patients are taking other medication, according to a new study from the University of Manchester. In some cases, patients were more than twice as likely to be hospitalised with an overdose if they were taking opioid agonists in combination with […] The post Overdose risk higher when opioid agonists prescribed with other medicines appeared first on The Pharmacist.

94

94

Med Ed 101

AUGUST 9, 2023

There’s always this voice in the back of my head that always cautions me that all that glitters is not gold. After being heralded as the next savior in weight loss by the media, the GLP-1 Agonists/GIP agonists have come under more scrutiny lately in the news. A recent article on CNN details patients who […] The post GLP-1 Agonists and Gastroparesis appeared first on Med Ed 101.

Diabetes 98

Diabetes 98

STAT

AUGUST 9, 2023

In yet another example of Covid’s seemingly limitless reach into our bodies, new research maps out how the SARS-CoV-2 virus disrupts mitochondria, the power plants in all our cells. The extent of the damage, spanning the lungs, heart, liver, kidneys, and brain, could potentially be one explanation for the lengthy list of persistent symptoms of long Covid , from fatigue to brain fog.

Immunity 246

Immunity Immunization 246

Drug Patent Watch

AUGUST 10, 2023

A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in the pharmaceutical industry for drug discovery and development. Results The… The post Artificial Intelligence and Machine Learning in Drug Discovery and Development appeared first on DrugPatentWatch - Make Better Decisions.

98

98

The Pharmacist

AUGUST 10, 2023

The NHS adult influenza vaccination programme will begin in October this year instead of on its usual September start date, NHS England (NHSE) has confirmed to The Pharmacist. An NHS spokesperson said that this was in order to ‘maximise protection for patients right across the winter months when it is typically colder, and viruses are […] The post Breaking: NSHE confirms October start for flu vaccinations appeared first on The Pharmacist.

Vaccines 95

Vaccines 95

BioPharma Dive

AUGUST 8, 2023

The job cuts will affect “all areas of the company” and, combined with other cost-reduction efforts, lead to annualized savings of over $100 million, Emergent said.

98

98

STAT

AUGUST 9, 2023

More than 2.5 years after the National Institutes of Health received a $1 billion mandate from Congress to study and treat long Covid , the agency has finally launched clinical trials for the often-debilitating condition. But both scientists who study long Covid and patients who have struggled with it say the trials are unlikely to deliver meaningful treatments, suggesting the federal government’s landmark Covid research effort may have been wasted.

246

246

The Honest Apothecary

AUGUST 10, 2023

Have you ever asked yourself this question: “What is the next step in my leadership journey?” It is a good question. Leadership is like climbing a mountain that has no pea or a ladder that has no top rung. Real leaders are generally hungry for the next challenge. They take a tough opportunity, give it their best, then start looking for the next giant to go after.

98

98

The Pharmacist

AUGUST 10, 2023

The price concession granted for Atorvastatin 80mg tablets dispensed in July 2023 has increased following a successful appeal from the community pharmacy negotiator. Community Pharmacy England (CPE) has announced the price concession has improved to a rate of £3.91, up from the previously imposed £3.45. And it noted this revised price was ‘high enough to […] The post Price increase for Atorvastatin 80mg dispensed in July appeared first on The Pharmacist.

Community Pharmacies 94

Community Pharmacies 94

European Pharmaceutical Review

AUGUST 10, 2023

The US Food and Drug Administration (FDA) has granted accelerated approval of TALVEY (talquetamab-tgvs) to treat multiple myeloma. Janssen Pharmaceutical Companies of Johnson & Johnson’s first-in-class bispecific T-cell engaging antibody showed an overall response rate (ORR) of over 70 percent in heavily pre-treated multiple myeloma. Based on this data, TALVEY is indicated for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, includin

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 9, 2023

Autistic people are at a much higher risk of self-harm leading to emergency care or suicide, according to a recent study published in JAMA Network Open. In particular, the study found, autistic females had an 83% increased risk of self-harm compared to non-autistic females, while for males, the increased risk compared to non-autistic individuals was 47%.

246

246

PharmExec

AUGUST 10, 2023

The application of artificial intelligence is steadily finding a home in the pharma industry, but these tools may have unprecedented potential in a more nascent niche along the life sciences continuum: drug development.

Drug Development 98

Drug Development 98

BioPharma Dive

AUGUST 8, 2023

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

The Pharmacist

AUGUST 9, 2023

Diabetes drug semaglutide, marketed as Wegovy, could also reduce risk of cardiovascular events by 20%, its manufacturer has claimed. Novo Nordisk has announced headline findings from its SELECT trial, although they have not yet been published in a peer-reviewed journal. The manufacturer said the trial achieved its primary objective of demonstrating a statistically significant reduction of major […] The post Semaglutide cuts risk of cardiovascular events by 20%, claims manufacturer appeared

Diabetes 93

Diabetes 93

STAT

AUGUST 8, 2023

WASHINGTON — A bipartisan group of senators wants federal tax regulators to probe nonprofit hospitals’ compliance with community benefit requirements, ratcheting up a longtime campaign to hold the tax-exempt providers accountable. Nonprofit hospitals are often subsidized by state or federal funding and exempt from many taxes. In exchange, they are required to aid their surrounding area through public health programs and providing free or discounted care to low-income patients.

Hospitals 246

Hospitals 246

PharmExec

AUGUST 8, 2023

The precision of programmatic advertising is reshaping the way life sciences brands engage with healthcare professionals, offering enhanced personalization, scale, and optimization in today's digital landscape.

98

98

Pharmaceutical Commerce

AUGUST 7, 2023

Creating a user-centric approach that harnesses both digital tools and behavioral science is key to getting—and maintaining—patients on therapy, and improving clinical, financial, and, ultimately, brand-success outcomes for pharma manufacturers.

98

98